Here’s the Latest Announcements from Today! Check out the latest updates from companies on Liquidity. Follow your favourite companies and get ASX Announcement Highlights, tailored just for you, delivered direct to your inbox. Recharge Metals Limited | $REC Pointerra | $3DP Wide Open Agriculture | $WOA Structural Monitoring Systems Plc | $SMN Buxton Resources | $BUX Chariot Corporation Ltd | $CC9 Argenica Therapeutics | $AGN Strategic Elements Ltd | $SOR Parkd | $PKD 🔗 - https://lnkd.in/gMUKDxdF #Liquidity #ASX #Investing #Announcements #MarketUpdates #InvestmentNews
Liquidity’s Post
More Relevant Posts
-
Regeneus trebles on back of merger deal This week’s Bulls N’ Bears ASX Runners of the Week is dominated by biotechs, with two showing big gains for punters. Line honours go to… Regeneus Ltd. Take a look at the full article here - The Sydney Morning Herald Regeneus Ltd - https://lnkd.in/e2BPwhXW #biotech #biotechnology #biology #technology
-
🚀 Exciting news in the biotech industry! Follow-on offerings are on pace to hit record levels by 2024, according to a recent report. #Biotech #Financing #IndustryTrends
Biotech stock fundings headed for best quarter in 3 years, Jefferies says
biopharmadive.com
-
Training and Development - Organizational Leadership - Employee Onboarding - ERG Event Planning Lead - Health & Wellness
🚀 Exciting news in the biotech industry! Follow-on offerings are on pace to hit record levels by 2024, according to a recent report. #Biotech #Financing #IndustryTrends
Biotech stock fundings headed for best quarter in 3 years, Jefferies says
biopharmadive.com
-
I help biopharma executives & investors build C-level relationships in the U.S., Europe, and Asia.
A sobering assessment of London’s AIM market from my BioCentury Inc. colleague Stephen Hansen, following the recent de-listings of three U.K. biotechs. 💬 “Anybody who lists on AIM should not be surprised that there’s low liquidity and they can’t raise secondary financing.” - Tim Haines of Abingworth 💬 ✅ Full analysis: https://lnkd.in/d5VNEEKG #biotech #capitalmarkets
Delisting biotechs take AIM at U.K. exchange
biocentury.com
-
Roses are red, violets are blue, Microbix's got news that'll make your heart skip a beat too! So mark your cals for February 14th because #Microbix will be releasing its financial statements and management disclosure for its first quarter of fiscal 2024, ending December 31, 2023. Don't miss it—RSVP now at https://bit.ly/3w6BPZF! #CanadianInvestors #InvestorWebinar #BioTech #InvestorRelations #AdCap #AdelaideCapital
-
-
Biotech is starting to show relative strength. We are using a ratio chart of IBB which is a biotech ETF vs the S&P 500. The price has broken out after a long downtrend. This does not mean that we will have positive returns. It means that we will outperform the returns of the S&P 500 returns. #biotechnology #IBB
-
-
🚀 Exciting news in the biotech industry! Follow-on offerings are on pace to hit record levels by 2024, according to a recent report. #Biotech #Financing #IndustryTrends
Biotech stock fundings headed for best quarter in 3 years, Jefferies says
biopharmadive.com
-
🚀 Exciting news in the biotech industry! Follow-on offerings are on pace to hit record levels by 2024, according to a recent report. #Biotech #Financing #IndustryTrends
Biotech stock fundings headed for best quarter in 3 years, Jefferies says
biopharmadive.com
-
Investor Communications | INS | InvestorsHub.com | Solum.Global | Investor Connect™️
NovaAccess - Stock Ticker XSNX closed a deal with Cedars, a partnership actually and the bounce has begun off that news. watch the open very very closely today as investors return from Passover. #Hotstock #Greatstock #Cheapstock #XSNX #Cedars #Biotech #Stemcells #Technology
-
-
In case you missed it: abrdn recently purchased Tekla Capital Management's advisory business. As part of the transaction, Abrdn now manages four healthcare and biotech thematic closed-end funds totaling $2.8 billion in assets under management (AUM). See the announcement and more CEFA Member updates you might have missed: https://lnkd.in/gBNigzpH #investing #investments #investmentmanagement #closedendfunds #cef #mutualfunds #healthcare #biotech
-
